Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Spectrochim Acta A Mol Biomol Spectrosc ; 325: 125099, 2024 Sep 06.
Artículo en Inglés | MEDLINE | ID: mdl-39260243

RESUMEN

In this study, the absorption and fluorescence characteristics of sulfa drugs, specifically Sulfadiazine (SDZ), Sulfamerazine (SMZ), and Sulfamethazine (STZ), were examined across a pH range of 1-14. The absorption and fluorescence spectra of these sulfa drugs showed significant changes depending on the pH value. Analysis of their pH-dependent absorption and fluorescence properties indicated that these sulfa drugs could used to design molecular logic gates. The absorption and fluorescence behaviors at various wavelength maxima were utilized to design IMPLICATION and Improved-INHIBIT (I-INHIBIT) molecular logic gates.

2.
Perm J ; 26(1): 47-56, 2022 04 05.
Artículo en Inglés | MEDLINE | ID: mdl-35609170

RESUMEN

INTRODUCTION: We sought to investigate the association between receipt of an opioid pain reliever (OPR) in the emergency department (ED) and downstream acute health care utilization. METHODS: Within Kaiser Permanente Northern California, we identified opioid-naïve patients, ages 18-64, who were treated and discharged from the ED for a painful, low-severity condition between January 1, 2017, and December 31, 2017. We also identified patients who received an OPR, either administered in the ED or obtained at a Kaiser Permanente Northern California pharmacy within 7 days of ED arrival, and investigated subsequent acute care utilization in cases with at least 1 ED, urgent care, or inpatient visit within 1 month or 3 months of the index encounter or 2 visits within 12 months. RESULTS: Of the 39,468 adults included in our study, 50.7% were female, 55.0% were non-White, and 25.2% received an OPR in association with their index ED encounter. After adjustment, we found that patients who received an OPR had greater odds of downstream acute care utilization than those who did not, with odds ratios of 1.68, 1.53, and 1.50 at 1, 3, and 12 months, respectively (all p < 0.05). CONCLUSION: Patients who received an OPR at their index encounter had substantially increased odds of a subsequent ED, urgent care, or inpatient visit. This effect was most pronounced early in follow-up and persisted for the duration of the study period. Receipt of an OPR among opioid-naïve adults for a painful, low-severity condition is associated with increased downstream acute care utilization.


Asunto(s)
Analgésicos Opioides , Servicio de Urgencia en Hospital , Adolescente , Adulto , Analgésicos Opioides/uso terapéutico , Femenino , Humanos , Masculino , Persona de Mediana Edad , Dolor/tratamiento farmacológico , Prescripciones , Estudios Retrospectivos , Adulto Joven
3.
Anal Chem ; 88(23): 11486-11490, 2016 12 06.
Artículo en Inglés | MEDLINE | ID: mdl-27934114

RESUMEN

The study reports the use of extended gate field-effect transistors (FET) for the label-free and sensitive detection of prostate cancer (PCa) biomarkers in human plasma. The approach integrates for the first time hybrid synthetic receptors comprising of highly selective aptamer-lined pockets (apta-MIP) with FETs for sensitive detection of prostate specific antigen (PSA) at clinically relevant concentrations. The hybrid synthetic receptors were constructed by immobilizing an aptamer-PSA complex on gold and subjecting it to 13 cycles of dopamine electropolymerization. The polymerization resulted in the creation of highly selective polymeric cavities that retained the ability to recognize PSA post removal of the protein. The hybrid synthetic receptors were subsequently used in an extended gate FET setup for electrochemical detection of PSA. The sensor was reported to have a limit of detection of 0.1 pg/mL with a linear detection range from 0.1 pg/mL to 1 ng/mL PSA. Detection of 1-10 pg/mL PSA was also achieved in diluted human plasma. The present apta-MIP sensor developed in conjunction with FET devices demonstrates the potential for clinical application of synthetic hybrid receptors for the detection of clinically relevant biomarkers in complex samples.


Asunto(s)
Técnicas Biosensibles , Oro/química , Óxidos/química , Antígeno Prostático Específico/sangre , Neoplasias de la Próstata/sangre , Receptores Artificiales/química , Aptámeros de Nucleótidos/sangre , Humanos , Masculino , Receptores Artificiales/síntesis química , Semiconductores , Transistores Electrónicos
4.
BMJ Open Diabetes Res Care ; 4(1): e000248, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27547418

RESUMEN

OBJECTIVE: To evaluate the acute impact of disasters on diabetic patients, we performed a geospatial analysis of emergency department (ED) use by New York City diabetic adults in the week after Hurricane Sandy. RESEARCH DESIGN AND METHODS: Using an all-payer claims database, we retrospectively analyzed the demographics, insurance status, and medical comorbidities of post-disaster ED patients with diabetes who lived in the most geographically vulnerable areas. We compared the patterns of ED use among diabetic adults in the first week after Hurricane Sandy's landfall to utilization before the disaster in 2012. RESULTS: In the highest level evacuation zone in New York City, postdisaster increases in ED visits for a primary or secondary diagnosis of diabetes were attributable to a significantly higher proportion of Medicare patients. Emergency visits for a primary diagnosis of diabetes had an increased frequency of certain comorbidities, including hypertension, recent procedure, and chronic skin ulcers. Patients with a history of diabetes visited EDs in increased numbers after Hurricane Sandy for a primary diagnosis of myocardial infarction, prescription refills, drug dependence, dialysis, among other conditions. CONCLUSIONS: We found that diabetic adults aged 65 years and older are especially at risk for requiring postdisaster emergency care compared to other vulnerable populations. Our findings also suggest that there is a need to support diabetic adults particularly in the week after a disaster by ensuring access to medications, aftercare for patients who had a recent procedure, and optimize their cardiovascular health to reduce the risk of heart attacks.

5.
Biomaterials ; 33(28): 6823-32, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22748768

RESUMEN

New biomaterials that have the ability to locally suppress an immune response could have broad therapeutic use in the treatment of diseases characterized by acute or chronic inflammation or as a strategy to facilitate improved efficacy in cell or tissue transplantation. We report here on the preparation of a modular peptide amphiphile (PA) capable of releasing an anti-inflammatory drug, dexamethasone (Dex), by conjugation via a labile hydrazone linkage. This molecule self-assembled in water into long supramolecular nanofibers when mixed with a similar PA lacking the drug conjugate, and the addition of calcium salt to screen electrostatic repulsion between nanofibers promoted gel formation. These nanofiber gels demonstrated sustained release of soluble Dex for over one month in physiologic media. The Dex released from these gels maintained its anti-inflammatory activity when evaluated in vitro using a human inflammatory reporter cell line and furthermore preserved cardiomyocyte viability upon induced oxidative stress. The ability of this gel to mitigate the inflammatory response in cell transplantation strategies was evaluated using cell-surrogate polystyrene microparticles suspended in the nanofiber gel that were then subcutaneously injected into mice. Live animal luminescence imaging using the chemiluminescent reporter molecule luminol showed a significant reduction in inflammation at the site where particles were injected with Dex-PA compared to the site of injection for particles within a control PA in the same animal. Histological evidence suggested a marked reduction in the number of infiltrating inflammatory cells when particles were delivered within Dex-PA nanofiber gels, and very little inflammation was observed at either 3 days or 21 days post-implantation. The use of Dex-PA could facilitate localized anti-inflammatory activity as a component of biomaterials designed for various applications in regenerative medicine and could specifically be a useful module for PA-based therapies. More broadly, these studies define a versatile strategy for facile synthesis of self-assembling peptide-based materials with the ability to control drug release.


Asunto(s)
Antiinflamatorios/administración & dosificación , Dexametasona/administración & dosificación , Inflamación/tratamiento farmacológico , Nanofibras/química , Animales , Antiinflamatorios/farmacocinética , Preparaciones de Acción Retardada , Dexametasona/farmacocinética , Geles/química , Geles/metabolismo , Humanos , Hidrazonas/química , Hidrazonas/farmacología , Inmunidad Innata/efectos de los fármacos , Inflamación/inmunología , Mediciones Luminiscentes , Ratones , Microscopía Electrónica de Transmisión , Monocitos/efectos de los fármacos , Miocitos Cardíacos/efectos de los fármacos , Nanofibras/ultraestructura , Estrés Oxidativo/efectos de los fármacos , Péptidos/química , Péptidos/metabolismo , Medicina Regenerativa , Tensoactivos/química , Tensoactivos/metabolismo
6.
Soft Matter ; 8(25): 2689-2692, 2012 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-22707978

RESUMEN

We report on the preparation of the first material for therapeutic delivery of CO. A peptide amphiphile was synthesized with a covalently attached ruthenium tricarbonyl. Self-assembled nanofiber gels containing this peptide spontaneously released CO with prolonged release kinetics compared to soluble CO donors. Oxidatively stressed cardiomyocytes had improved viability when treated with this peptide, demonstrating its potential as a biodegradable gel for localized therapeutic CO delivery.

7.
Dermatol Clin ; 29(3): 393-404, vii-iii, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21605804

RESUMEN

The authors developed an anonymous, Web-based survey instrument available globally, and collected data from 171 pemphigus vulgaris (PV) patients to assemble epidemiologic data pertaining to an extensive set of clinical parameters in demographically diverse populations. The results showed female predominance, prevalent onset of disease in the fifth decade of life, and a strong correlation of PV with thyroid disease and type 1 diabetes in patients and family members. Most patients have a history of either mucosal-only or mucocutaneous lesions, but numerous patients self-report cutaneous lesions only, without previous or concurrent mucosal lesions, especially in the non-North American PV population.


Asunto(s)
Salud Global , Encuestas Epidemiológicas/estadística & datos numéricos , Internet/estadística & datos numéricos , Pénfigo/epidemiología , Pénfigo/patología , Adulto , Edad de Inicio , Anciano , Anciano de 80 o más Años , Candidiasis/epidemiología , Comorbilidad , Infecciones por Virus de Epstein-Barr/epidemiología , Salud de la Familia , Femenino , Hepatitis C/epidemiología , Herpes Simple/epidemiología , Herpes Zóster/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Infecciones Estafilocócicas/epidemiología , Infecciones Estreptocócicas/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA